Elevated serum α-synuclein autoantibodies in patients with Parkinson’s disease relative to Alzheimer’s disease and controls
Early diagnosis of neurodegenerative diseases is of paramount importance for successful treatment. Lack of sensitive and early biomarkers for diagnosis of diseases like Parkinson’s disease (PD) is a handicapping problem for all movement disorders specialists. Using serum autoimmune antibodies (AI...
| Main Authors: | Shalash, Ali, Salama, Mohamed, Makar, Marianne, Roushdy, Tamer, Elrassas, Hannan hany, Mohamed, Wael Mohamed Yousef, ElBalkimy, Mahmoud, Abu Donia, Mohamed |
|---|---|
| Format: | Article |
| Language: | English English |
| Published: |
Frontiers Media S.A.
2017
|
| Subjects: | |
| Online Access: | http://irep.iium.edu.my/60803/ http://irep.iium.edu.my/60803/1/Alpha%20Syneculin%20Frontier.pdf http://irep.iium.edu.my/60803/7/60803_Elevated%20serum_scopus.pdf |
Similar Items
Tubulin and tau: Possible targets for diagnosis of Parkinson’s and Alzheimer’s diseases
by: Salama, Mohamed, et al.
Published: (2018)
by: Salama, Mohamed, et al.
Published: (2018)
Genetic underpinnings in Alzheimer’s disease –
A review
by: Moustafa, Ahmed A., et al.
Published: (2017)
by: Moustafa, Ahmed A., et al.
Published: (2017)
Effect of intranasal stem cell administration on the nigrostriatal system in a mouse model of Parkinson's disease
by: Salama, Mohamed, et al.
Published: (2017)
by: Salama, Mohamed, et al.
Published: (2017)
Manganese exposure: linking down-regulation of miRNA-7 and miRNA-433 with α-synuclein overexpression and risk of idiopathic Parkinson's disease
by: Tarale, Prashant, et al.
Published: (2018)
by: Tarale, Prashant, et al.
Published: (2018)
C-Abl inhibition; a novel therapeutic target for Parkinson’s disease
by: Abushouk, Abdelrahman Ibrahim, et al.
Published: (2018)
by: Abushouk, Abdelrahman Ibrahim, et al.
Published: (2018)
Pharmacotherapy of alzheimer’s disease: seeking clarity in a time of uncertainty
by: Ibrahim, Nurul Husna, et al.
Published: (2020)
by: Ibrahim, Nurul Husna, et al.
Published: (2020)
Natural and disease-specific autoantibodies in chronic obstructive pulmonary disease
by: Daffa, N.I., et al.
Published: (2014)
by: Daffa, N.I., et al.
Published: (2014)
Genome-wide analysis of genetic correlation in dementia with Lewy bodies, Alzheimer’s and Parkinson’s diseases
by: Guerreiro, Rita, et al.
Published: (2016)
by: Guerreiro, Rita, et al.
Published: (2016)
Integrating nutriepigenomics in Parkinson's disease management: new promising strategy in the omics era
by: Razali, Khairiah, et al.
Published: (2022)
by: Razali, Khairiah, et al.
Published: (2022)
Profiling natural autoantibodies in relation to chronic obstructive pulmonary disease
by: Halala, Ramadan
Published: (2017)
by: Halala, Ramadan
Published: (2017)
The unified parkinson's disease rating scale score in parkinson's disease patients with and without cognitive impairment
by: Hilmi, Abdullah
Published: (2007)
by: Hilmi, Abdullah
Published: (2007)
Parkinson disease gait classification based on machine learning approach / Hany Hazfiza Manap
by: Manap, Hany Hazfiza
Published: (2013)
by: Manap, Hany Hazfiza
Published: (2013)
Diet and Alzheimer's disease
by: Creegan, R., et al.
Published: (2013)
by: Creegan, R., et al.
Published: (2013)
Models of Alzheimer’s Disease
by: Chen, M., et al.
Published: (2014)
by: Chen, M., et al.
Published: (2014)
Alzheimer's disease talk
by: The Star,
Published: (2012)
by: The Star,
Published: (2012)
Treatment of depression and anxiety in Parkinson’s Disease
by: Troeung, Lakkhina
Published: (2013)
by: Troeung, Lakkhina
Published: (2013)
The Measurement and Nature of Impulsivity in Parkinson’s disease
by: Booth, Leon David
Published: (2020)
by: Booth, Leon David
Published: (2020)
Beneficial role of vitexin in Parkinsons disease
by: Mustapha, Musa, et al.
Published: (2023)
by: Mustapha, Musa, et al.
Published: (2023)
Alzheimer disease: gene therapy and natural product research
by: Doolaanea, Abd Almonem, et al.
Published: (2018)
by: Doolaanea, Abd Almonem, et al.
Published: (2018)
Profiling autoantibodies in chronic obstructive pulmonary disease using antigen microarray technology
by: Shindi, Reham
Published: (2016)
by: Shindi, Reham
Published: (2016)
Transgenic nematodes as a model for Parkinson’s disease
by: Bodhicharla, Rakesh Kumar
Published: (2012)
by: Bodhicharla, Rakesh Kumar
Published: (2012)
Analysis of mitochondrial haemoglobin in Parkinson's disease brain
by: Shephard, Freya, et al.
Published: (2016)
by: Shephard, Freya, et al.
Published: (2016)
Literature Review on Acupuncture Treatment for Parkinson’s Disease
by: Teng, Le-xus, et al.
Published: (2024)
by: Teng, Le-xus, et al.
Published: (2024)
The role of endocannabinoids in Alzheimer's disease
by: Maroof, Nazia
Published: (2013)
by: Maroof, Nazia
Published: (2013)
Animal Models of Alzheimer's Disease
by: Newman, M., et al.
Published: (2017)
by: Newman, M., et al.
Published: (2017)
Molecular Genetics of Alzheimer's Disease
by: Verdile, Giuseppe, et al.
Published: (2009)
by: Verdile, Giuseppe, et al.
Published: (2009)
Consumption of fish and Alzheimer's Disease
by: Newton, Wendy, et al.
Published: (2011)
by: Newton, Wendy, et al.
Published: (2011)
Development of hippocampus MRI image segmentation algorithm for progression detection of alzheimer’s disease (AD)
by: Gilani Mohamed, Mohamed Ahmed
Published: (2022)
by: Gilani Mohamed, Mohamed Ahmed
Published: (2022)
Impulse control behaviours in a Malaysian Parkinson’s disease population
by: Md. Rani, Shahrul Azmin, et al.
Published: (2016)
by: Md. Rani, Shahrul Azmin, et al.
Published: (2016)
Intelligent glove for suppression of resting tremor in parkinson’s disease
by: M. Zulkefli, Adibah, et al.
Published: (2019)
by: M. Zulkefli, Adibah, et al.
Published: (2019)
Limbic grey matter changes in early Parkinson's disease
by: Li, Xingfeng, et al.
Published: (2017)
by: Li, Xingfeng, et al.
Published: (2017)
Nonpharmacological Interventions for Mild Cognitive Impairment in Parkinson’s Disease
by: Lawrence, Blake Justin
Published: (2016)
by: Lawrence, Blake Justin
Published: (2016)
A Bayesian Evaluation of Subtyping Methods in Parkinson’s Disease
by: Johnson, Andrew Robert
Published: (2019)
by: Johnson, Andrew Robert
Published: (2019)
Factor Structure of the Ways of Coping Questionnaire in Parkinson's Disease
by: Corti, E., et al.
Published: (2018)
by: Corti, E., et al.
Published: (2018)
Motor Heterogeneity in Parkinson's Disease: A Bayesian Perspective
by: Johnson, A., et al.
Published: (2017)
by: Johnson, A., et al.
Published: (2017)
Cognitive reserve, executive function, and memory in parkinson’s disease
by: Loftus, Andrea, et al.
Published: (2021)
by: Loftus, Andrea, et al.
Published: (2021)
Predicting Parkinson’s Disease Using Machine Learning Model
by: Sanjay Aswath, K.S.M, et al.
Published: (2024)
by: Sanjay Aswath, K.S.M, et al.
Published: (2024)
Suitability of the depression, anxiety, and stress scale in Parkinson's disease
by: Johnson, A., et al.
Published: (2016)
by: Johnson, A., et al.
Published: (2016)
Prevalence and Subtypes of Mild Cognitive Impairment in Parkinson's Disease.
by: Lawrence, B., et al.
Published: (2016)
by: Lawrence, B., et al.
Published: (2016)
Validity of driving simulator in assessing drivers with Parkinson's Disease
by: Lee, Hoe, et al.
Published: (2008)
by: Lee, Hoe, et al.
Published: (2008)
Similar Items
-
Tubulin and tau: Possible targets for diagnosis of Parkinson’s and Alzheimer’s diseases
by: Salama, Mohamed, et al.
Published: (2018) -
Genetic underpinnings in Alzheimer’s disease –
A review
by: Moustafa, Ahmed A., et al.
Published: (2017) -
Effect of intranasal stem cell administration on the nigrostriatal system in a mouse model of Parkinson's disease
by: Salama, Mohamed, et al.
Published: (2017) -
Manganese exposure: linking down-regulation of miRNA-7 and miRNA-433 with α-synuclein overexpression and risk of idiopathic Parkinson's disease
by: Tarale, Prashant, et al.
Published: (2018) -
C-Abl inhibition; a novel therapeutic target for Parkinson’s disease
by: Abushouk, Abdelrahman Ibrahim, et al.
Published: (2018)